ZYUS Life Sciences Corporation (the "ZYUS" and or "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel drug product candidates for ...

RINGANA, the Austrian skincare and life science company known for its freshly produced cosmetics and supplements, will officially enter the United States in November 2026, marking a major new chapter ...

Luma Group has closed its inaugural life sciences venture capital fund, LumaBio Fund I, with $410 million in committed ...

BioTech Social Inc. (BSI) has established an advisory board of experts from various fields to enhance financial ...

SELLAS Life Sciences is rated Hold, with a $9.25 price target, as the current valuation reflects REGAL trial success ...

The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion. Caris Life Sciences, a cancer diagnostics company based in Irving, Texas, uses gene ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

USC Dornsife has given four longstanding fields clearer academic identities, increasing their visibility in research and graduate education.

Life sciences companies have long relied on evergreening strategies to strengthen patent exclusivity around innovative therapies.

Next-generation upgrade strengthens data comparability and compliance—without changing trusted instrumentation ...